Ann: Change of Company Name-MNQ.AX, page-32

First 32 Last

Share
Profile

Follow
longwalker

722 Posts.

151

29/09/16

21:36

Post #: 19521995
Share

Originally posted by Quinten ↑

Hi all, can't wait for ePAT to get listed, looks like there's huge potential.
However just want to discuss about the "pre-verbal children" target market they're developing for soon.

As a parent, if my 1yr old is sick or in "pain" I would just use the recommended dose of panadol or nerofen, regardless of the "pain scale" the toddler is experiencing.
I can understanding for aged old people to vary the painkillers depending on the pain. But for toddlers and babies, parents don't want to risk long term damage giving them 2 shots of painkillers, they'll just go to the doctors if it gets worse.
So would parents still need the ePAT app to tell them this? Is this a big market to develop for.. .after taking on the dementia market?

Also another thing I'm worried about is the "Use of Funds – 2 year budget" on their end of August presentation.
If the funds are to last them without any CR for 2 yrs, their sales and marketing seems at bit low especially if they're going to target 2 markets. Their corp & admin is more than their R&D and S&M combined.

Any civil discussion on this would be greatly appreciated, thank you.

Capital Raising Fees $340,000 9%

Research & Development $973,000 24%

Sales & Marketing $511,000 13%

Intellectual Property & Regulatory $225,000 6%

Corporate & Administration $1,671,000 42%

Working Capital $280,000 7%

Expand

Pre verbal kids you describe can't communicate so it is the parent who judges if they are in pain and in today increasing reliance on prescription drugs a lot of parents adopt a philosophy of not wanting to administer drugs to their babies / toddlers unless absolutely needed.

Other markets drug companies testing objectively the effectiveness of prototype pain killer drugs.
Injury compensation industry and fraudulent claims particularly in today's litigation society.

Last edited by longwalker: 29/09/16

MNQ Price at posting: 0.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

RCE

Recce's R327 found effective against E.coli during clinical trial

Microcap Wrap: 5 explorers with news out today

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

3DP

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios